# TherapeuticsMD, Inc.: Form 8-K, filed Oct 3, 2022

- Company: [TherapeuticsMD, Inc.](/companies/txmd.md) (CIK 25743)
- Form: 8-K
- Filed: 2022-10-03
- Accepted by EDGAR: Oct 3, 2022, 07:00 ET
- Period: 2022-09-30
- Accession: 0001193125-22-256102
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/25743/000119312522256102/d378570d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/25743/000119312522256102/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/25743/000119312522256102/d378570d8k.htm

Filed Oct 3, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-256102. Last ingested by Listed: Nov 14, 2026, 19:24 ET. No prices; not investment advice.
